AETNA INC
8-K, 1996-10-25
HOSPITAL & MEDICAL SERVICE PLANS
Previous: AETNA INC, 10-Q, 1996-10-25
Next: SIMULATION SCIENCES INC, 424B4, 1996-10-25



<PAGE> 1

                         SECURITIES AND EXCHANGE COMMISSION

                               Washington, D.C.  20549

                                      Form 8-K

                   Current Report Pursuant to Section 13 or 15(d)
                       of the Securities Exchange Act of 1934



        Date of report (Date of earliest event reported)    July 19, 1996   
                                                         ___________________


                                      Aetna Inc.                               
        _______________________________________________________________________
                (Exact name of registrant as specified in its charter)


                                      Connecticut                              
        _______________________________________________________________________
                    (State or other jurisdiction of incorporation)


               1-11913                                  02-0488491            
        ______________________________________________________________________
        (Commission File Number)                      (I.R.S. Employer
                                                       Identification No.)


        151 Farmington Avenue, Hartford, Connecticut           06156           
        _______________________________________________________________________
        (Address of principal executive offices)             (ZIP Code)


        Registrant's telephone number, including area code     (860) 273-0123  
                                                             __________________


                                    Not Applicable                             
        _______________________________________________________________________
            (Former name or former address, if changed since last report)



<PAGE> 2

                               TABLE OF CONTENTS
                               _________________


                                                                    Page
                                                                    ____

        Item 5.     Other Information.                  .             3


        Item 7(b).  Pro Forma Financial Information.                  3


        Signatures                                                    9


<PAGE> 3

Item 5.  Other Information.

Unaudited pro forma condensed consolidated statements of income of 
Aetna Inc. for the nine months ended September 30, 1996 and the 
twelve months ended December 31, 1995 are filed herewith under 
Item 7(b).


Item 7(b). Pro Forma Financial Information.

                UNAUDITED PRO FORMA FINANCIAL INFORMATION

On July 19, 1996, Aetna Services, Inc. ("Aetna") (formerly Aetna Life 
and Casualty Company) and U.S. Healthcare, Inc. ("U.S. Healthcare") 
respectively merged (respectively, the "Aetna Sub Merger" and the 
"U.S. Healthcare Sub Merger", and collectively, the "Mergers") with 
separate subsidiaries of a new holding company, Aetna Inc. ("Parent") 
and both Aetna and U.S. Healthcare became wholly-owned subsidiaries 
of Parent.  The Mergers were effected pursuant to a definitive 
agreement, dated as of March 30, 1996, as amended by Amendment No. 1 
thereto dated as of May 30, 1996 (as so amended, the "Merger 
Agreement") among Aetna, U.S. Healthcare, Parent and such 
subsidiaries.

The following unaudited pro forma condensed consolidated statements 
of income of Parent for the nine months ended September 30, 1996 and 
the twelve months ended December 31, 1995 present results for Parent 
as if each of the following had occurred as of January 1, 1996 and 
January 1, 1995, respectively:  (i) the consummation of the sale by 
Aetna of its property-casualty operations to an affiliate of The 
Travelers Insurance Group Inc. (the "Property-Casualty Sale") and 
(ii) the consummation of the Mergers (including associated borrowings 
and related transactions).

The U.S. Healthcare Sub Merger was accounted for under the purchase 
method of accounting.  Accordingly, the amount of the consideration 
paid in the U.S. Healthcare Sub Merger was allocated to assets 
acquired and liabilities assumed based on their fair values.  The 
excess of such consideration over the fair value of such assets and 
liabilities has been allocated to goodwill and certain identifiable 
intangible assets.  The purchase price allocation may be adjusted 
within the year following the merger to reflect changes in the final 
valuations of U.S. Healthcare's assets and liabilities.  The effect 
of any such adjustment is not expected to be significant.  The Aetna 
Sub Merger was treated as a reorganization with no change in the 
recorded amount of Aetna's assets and liabilities.  The pro forma 
condensed consolidated financial statements do not give effect to any 
synergies which may be realized as a result of the Mergers.  
Additionally, except as indicated in the notes thereto, the pro forma 
condensed consolidated financial statements do not reflect any 
nonrecurring/unusual restructuring charges that will be incurred as a 
result of the integration of Aetna's and U.S. Healthcare's combined 
health operations (the "Combined Health Operations").  Integration 
charges of $423.1 million (pretax, $275.0 million after tax) will be 
recorded by Parent in the fourth quarter of 1996.


<PAGE> 4

Item 7(b). Pro Forma Financial Information.  (Continued)

The unaudited pro forma condensed consolidated statements of income 
are provided for informational purposes only and do not purport to 
represent what the Parent's results of operations actually would have 
been had the Property-Casualty Sale and the Mergers in fact occurred 
on the dates indicated, or to project the Parent's results of 
operations for any future date or period.

The unaudited pro forma condensed consolidated statements of income 
are based on the historical consolidated financial statements of 
Parent and U.S. Healthcare and should be read in conjunction with 
such historical financial statements, and the notes thereto, which 
are included in the annual reports on Form 10-K of Aetna and Form 10-
K, as amended, of U.S. Healthcare for the year ended December 31, 
1995 and the quarterly reports on Form 10-Q of Parent for the quarter 
ended September 30, 1996 and U.S. Healthcare for the quarter ended 
March 31, 1996 (see also information regarding factors affecting 
forward-looking information included in such reports).


<PAGE> 5


                                 Aetna Inc.
      Unaudited Pro Forma Condensed Consolidated Statement Of Income
                  For the Nine Months Ended September 30, 1996
                 (in millions, except share and per share data)

<TABLE>
<CAPTION>
                                                                                         Pro Forma
                                                  Pro Forma                                    U.S.
                                       Aetna      Property-        Aetna         U.S.   Healthcare       Aetna
                                        Inc.  Casualty Sale         Inc.   Healthcare       Merger       Inc.(n)
                                  Historical  Adjustments(d) As Adjusted   Historical  Adjustments(e) As Adjusted
                                  __________  ______________ ___________  ___________  ______________ ___________
<S>                               <C>          <C>           <C>          <C>          <C>            <C>       

Revenue:

Premiums                          $  6,243.1   $        -    $   6,243.1  $   2,331.4  $         -    $  8,574.5
Net investment income, including
 net realized capital gains          2,751.9            - (a)    2,751.9         37.2        (56.6)(f)   2,732.5
                                                                                                                
Fees and other income                1,624.8            -        1,624.8         53.3            -       1,678.1
                                  ______________________________________________________________________________

Total revenue                       10,619.8            -       10,619.8      2,421.9        (56.6)     12,985.1
________________________________________________________________________________________________________________

Benefits and Expenses:

Current and future benefits          7,157.0            -        7,157.0      1,764.6            -       8,921.6
Operating expenses                   2,499.2            -        2,499.2        432.7          4.7 (g)   2,888.8
                                                                                              56.9 (h)
                                                                                            (114.1)(l)
                                                                                               9.4 (m)
Amortization of deferred policy
 acquisition costs                     123.5            -          123.5            -            -         123.5
Amortization of goodwill and
 identifiable intangible assets         80.8            -           80.8            -        195.2 (j)     276.0
Reduction of loss on discontinued
 products                             (170.0)           -         (170.0)           -            -        (170.0)
Severance and facilities charges       441.7            -          441.7            -            - (k)     441.7
                                  ______________________________________________________________________________

Total benefits and expenses         10,132.2            -       10,132.2      2,197.3        152.1      12,481.6
________________________________________________________________________________________________________________

Income from continuing operations
 before income taxes (benefits)
 and preferred stock dividends         487.6            -          487.6        224.6       (208.7)        503.5

Income taxes (benefits)                175.4            -          175.4        100.1        (19.8)(f)     222.5
                                                                                              (1.8)(g)
                                                                                             (19.9)(h)
                                                                                              27.0 (l)
                                                                                             (34.9)(j)
                                                                                              (3.6)(m) 
                                  ______________________________________________________________________________


Income from continuing operations      312.2            -          312.2        124.5       (155.7)        281.0

Dividends on mandatorily 
 convertible preferred stock           (11.2)           -          (11.2)           -        (30.5)(i)     (41.7)
                                  _______________________________________________________________________________

Income from continuing operations
 attributable to common ownership $    301.0   $        -     $    301.0   $    124.5   $   (186.2)   $    239.3
                                  ______________________________________________________________________________
                                  ______________________________________________________________________________

Results Per Common Share:
Primary:
Income from continuing 
 operations                       $     2.39                  $     2.39                              $     1.58
                                  __________                  __________                              __________
                                  __________                  __________                              __________
  Weighted average common shares
   and commom share equivalents 
   outstanding                   126,138,464                 126,138,464                             151,722,611*
                                 ___________                 ___________                             ___________ 

<FN>

* Pro forma weighted average common shares outstanding reflect Aetna's third quarter 1996 
  weighted average common shares outstanding and the issuance by Parent of 34,988,615 
  shares of Parent Common Stock in connection with the U.S. Healthcare Sub Merger, as 
  though all such shares were issued and outstanding on January 1, 1996.  No conversion of 
  mandatorily convertible preferred stock issued in connection with the Mergers is assumed.
</TABLE>

See Notes to Unaudited Pro Forma Condensed Consolidated Financial Statements.


<PAGE> 6


                                 Aetna Inc.
      Unaudited Pro Forma Condensed Consolidated Statement Of Income
                  For the Year Ended December 31, 1995
              (in millions, except share and per share data)

<TABLE>
<CAPTION>
                                                                                        Pro Forma
                                                 Pro Forma                                    U.S. 
                                      Aetna      Property-         Aetna         U.S.   Healthcare       Aetna
                                       Inc.  Casualty Sale          Inc.   Healthcare       Merger       Inc.(n)
                                 Historical  Adjustments(d)  As Adjusted   Historical  Adjustments(e) As Adjusted
                                 __________  ______________  ___________  ___________  ______________ ___________
<S>                              <C>         <C>             <C>          <C>          <C>            <C>       

Revenue:

Premiums                         $  7,431.4  $        -      $  7,431.4   $  3,486.3   $        -    $ 10,917.7
Net investment income, including
 net realized capital gains         3,622.3           - (a)     3,622.3         91.9            - (f)   3,714.2
Fees and other income               1,924.3           -         1,924.3         55.7            -       1,980.0
                                 ______________________________________________________________________________

Total revenue                      12,978.0           -        12,978.0      3,633.9            -      16,611.9 
_______________________________________________________________________________________________________________ 

Benefits and Expenses:

Current and future benefits         9,027.2           -         9,027.2      2,527.5            -      11,554.7
Operating expenses                  3,072.3        17.0 (b)     3,089.3        487.4         11.8 (g)   3,699.7
                                                                                            103.3 (h)
Amortization of deferred policy                                                               7.9 (m)
 acquisition costs                    137.1           -           137.1            -                      137.1
Amortization of goodwill and 
 identifiable intangible assets        15.2           -            15.2            -        356.0 (j)     371.2
Severance and facilities charges          -           - (c)           -            -            - (k)         -
                                 ______________________________________________________________________________

Total benefits and expenses        12,251.8        17.0        12,268.8      3,014.9        479.0      15,762.7
_______________________________________________________________________________________________________________

Income from continuing operations
 before income taxes (benefits)
 and preferred stock dividends        726.2       (17.0)          709.2        619.0       (479.0)        849.2

Income taxes (benefits)               252.3        (5.9)(b)       246.4        238.3         (4.5)(g)     377.7
                                                                                            (36.1)(h)
                                                                                            (63.6)(j)
                                                                                             (2.8)(m)          
                                 ______________________________________________________________________________

Income from continuing operations     473.9       (11.1)          462.8        380.7       (372.0)        471.5

Dividends on mandatorily 
 convertible preferred stock              -           -               -            -        (55.6)(i)     (55.6)
                                 ______________________________________________________________________________ 

Income from continuing operations
 attributable to common
 ownership                       $    473.9  $    (11.1)     $    462.8   $    380.7   $   (427.6)   $    415.9
                                 ______________________________________________________________________________
                                 ______________________________________________________________________________

Results Per Common Share:
Primary:
Income from continuing 
 operations                      $     4.16                  $     4.06                              $     2.79
                                 __________                  __________                              __________
                                 __________                  __________                              __________
  Weighted average common shares
   and share equivalents 
   outstanding                  113,897,633                 113,897,633                             149,251,761*
                                ___________                 ___________                             ___________ 

<FN>

* Pro forma weighted average common shares outstanding reflects Aetna's 1995 weighted 
  average common shares outstanding and the issuance by Parent of 34,988,615 common shares 
  in connection with the U.S. Healthcare Sub Merger, as though all such shares were issued 
  and outstanding on January 1, 1995.  No conversion of the Parent Mandatorily Convertible 
  Preferred Stock is assumed.
</TABLE>

See Notes to Unaudited Pro Forma Condensed Consolidated Financial Statements.


<PAGE> 7

                              Aetna Inc.
                     Notes To Unaudited Pro Forma
              Condensed Consolidated Financial Statements

Pro Forma Adjustments Related to the Property-Casualty Sale:
____________________________________________________________

a.  No adjustment has been made to reflect interest income for the 
    period January 1, 1996 through April 2, 1996 at 4.93% and a 
    full year of interest income at 5.49% in 1995 (average 3 month 
    Treasury bill rates for the periods) on net proceeds from the 
    Property-Casualty Sale (after giving effect to the payment of 
    transaction costs and liabilities associated with the sale) of 
    approximately $3.9 billion.  The amount of such adjustments 
    (after tax) would approximate $31.3 million for the period 
    January 1, 1996 through April 2, 1996 and $139.2 million for 
    the twelve months ended December 31, 1995.

b.  Pro forma adjustment to reflect a full year of interest 
    expense (an additional 11.2 months) at 6.01% in 1995 (average 
    commercial paper rate for the period), and related income tax 
    benefits, on the capital contribution by Aetna of $303 million 
    to the property-casualty operations.  Such capital contribution
    was actually made on December 6, 1995.

c.  No adjustment has been made to give effect to the 
    restructuring charges related to the Property-Casualty Sale, 
    including those related to the sublease of the CityPlace 
    office facility and other facility and severance charges.  
    Such charges ($362.7 million pretax, $235.5 million after tax) 
    were recorded by Aetna in the second quarter of 1996.

d.  No adjustment has been made to reflect the historical results 
    of Aetna's discontinued property-casualty operations.  Such 
    results were $182.2 million (or $1.57 per Common Share) of net 
    income for the period January 1, 1996 through April 2, 1996 
    and $222.2 million of a net loss (or $1.95 per Common Share) 
    for the twelve months ended December 31, 1995.

Pro Forma Adjustments Related to the Mergers:
_____________________________________________

e.  No adjustment has been made to give effect to any synergies 
    which may be realized as a result of the Mergers.

f.  Pro forma adjustment to reflect a reduction in interest income 
    for the period April 2, 1996 through July 19, 1996 on 
    that portion of the cash consideration paid at closing of the 
    U.S. Healthcare Sub Merger from the Property-Casualty Sale 
    proceeds.  No such adjustment has been made for the period 
    January 1, 1996 through April 2, 1996 since such 
    interest income is not reflected in the pro forma financial 
    statements (see adjustment a).

g.  Pro forma adjustment to conform the U.S. Healthcare accounting 
    policies with those of Aetna related to expensing rather than 
    capitalizing costs primarily relating to purchased and 
    internally developed software, printed and other promotional 
    items, and the related income tax effect.

h.  Pro forma adjustment to reflect assumed interest expense of 
    7.38% on $1.4 billion of borrowings incurred in connection 
    with the U.S. Healthcare Sub Merger, and the related income 
    tax effect.


<PAGE> 8

                              Aetna Inc.
                     Notes To Unaudited Pro Forma
              Condensed Consolidated Financial Statements

Pro Forma Adjustments Related to the Mergers (Continued):
_________________________________________________________

i.  Pro forma adjustment to reflect the dividends on the 
    $865 million of the mandatorily convertible preferred stock 
    issued in connection with the Mergers.  In determining pro 
    forma earnings per share, mandatorily convertible 
    preferred stock is not considered a common stock equivalent 
    and is antidilutive.

j.  Pro forma adjustment to reflect the amortization of the 
    approximately $7.9 billion excess of the purchase price over 
    the estimated fair value of the net assets acquired using a 
    range of estimated useful lives for identifiable intangible 
    assets of 5 to 25 years and a 40 year useful life for goodwill 
    (37 year weighted average life), and the related income tax 
    effect on intangibles other than goodwill.

k.  No adjustment has been made to give effect to any non-
    recurring/unusual restructuring charges that may be incurred 
    as a result of the integration of the health operations of 
    Aetna and U.S. Healthcare.  Integration charges of $423.1 
    million (pretax, $275.0 million after tax) will be recorded by 
    Parent in the fourth quarter of 1996.

l.  Pro forma adjustment to remove the effect of nonrecurring 
    merger-related costs, including transaction fees and expenses, 
    and charges incurred as a result of an Agreement with the 
    principal shareholder of U.S. Healthcare (the "Agreement with 
    Principal Shareholder") and employment agreements with U.S. 
    Healthcare executives (the "Employment Agreements") in the 
    first nine months of 1996 and the related income tax effect.

m.  Pro forma adjustment to reflect recurring expenses incurred
    as a result of the Agreement with Principal Shareholder and
    the Employment Agreements and the related income tax effect.

n.  Reflects the conversion of Aetna common stock into Parent 
    common stock (including the cancellation of shares held in
    treasury).

<PAGE> 9

                       SIGNATURES

Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly
authorized.






                                            Aetna Inc.         
                                   ____________________________
                                           (Registrant)


Date  October 25, 1996         By /s/ Robert J. Price         
                                  ____________________________
                                      (Signature)

                                      Robert J. Price
                                      Vice President and 
                                      Corporate Controller
                                      (Chief Accounting Officer)





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission